Linseed
Lini semen
Linum usitatissimum L.
HOS-215944hmpc:lini-semen
Botanische Abbildung
Linum usitatissimum , Linaceae, Flax, Linseed, habitus. The fresh, aerial parts of blooming plants are used in homeopathy as remedy: Linum usitatissimum (Linu-u.)
Artbezogene Illustration. Sie zeigt nicht automatisch die im Profil genannte Arzneidroge oder Zubereitung und dient nicht zur sicheren Bestimmung einer Giftpflanze.
H. Zell · CC BY-SA 3.0 · Bildquelle ↗
Bildzuordnung & Herkunft
- Originalangabe im Profil
- Linum usitatissimum L.
- Taxonkennung
- Q45108 · Quellenrevision 2559678491
- Bearbeitung
- Auf maximal 1024 Pixel verkleinert, EXIF-Orientierung angewandt und als JPEG gespeichert; kein inhaltlicher Zuschnitt.
- Bildquelle abgerufen
- 25.10.2026
Bilddatei SHA-256: 5f7b6e1455cb6ed86f1ea81a25d1c36964f6bf733145c78b2223fa6cddfb34c7
- Themengebiete laut EMA
- Constipation;Gastrointestinal disorders
- Ergebnis der Bewertung laut EMA
- European Union herbal monograph
- Kombination laut EMA
- Nein
Pflanzen–Arzneimittel-Beziehungen 1 belegte Zuordnungen
Warnungen, berichtete Effekte und verneinte Studienbefunde werden getrennt ausgewiesen und mit eindeutig bezeichneten Wirkstoffen verknüpft. Jede Aussage gilt im Zubereitungs- und Anwendungskontext der Quelle. Ein klinischer Schweregrad wird daraus nicht abgeleitet.
loperamide
Ausdrückliche EinschränkungEtablierte Anwendung · Quellenspalte · Laut Quelle unter ärztlicher Überwachung · Schweregrad: nicht angegeben
HOS-215944HOS-114855RxNorm 6468
In order to decrease the risk of gastrointestinal obstruction (ileus), linseed should be used together with medicinal products known to inhibit peristaltic movement (e.g. opioids, loperamide) only under medical supervision.
Zubereitungskontext & Beleg
Wortlaut der zugeordneten Aussage:
In order to decrease the risk of gastrointestinal obstruction (ileus), linseed should be used together with medicinal products known to inhibit peristaltic movement (e.g. opioids, loperamide) only under medical supervision.
1. Name of the medicinal product To be specified for the individual finished product. 2. Qualitative and quantitative composition 1,2 Well-established use Traditional use With regard to the marketing authorisation With regard to the registration application of application of Article 10(a) of Directive Article 16d(1) of Directive 2001/83/EC as 2001/83/EC as amended amended Linum usitatissimum L., semen (linseed) Linum usitatissimum L., semen (linseed) i) Herbal substance i) Herbal substance As defined in the Ph. Eur. monograph As defined in the Ph. Eur. monograph ii) Herbal preparations ii) Herbal preparations not applicable not applicable 3. Pharmaceutical form Well-established use Traditional use Herbal substance for oral use. Herbal substance for oral use. The pharmaceutical form should be described by The pharmaceutical form should be described by the European Pharmacopoeia full standard term. the European Pharmacopoeia full standard term. 4. Clinical particulars 4.1. Therapeutic indications Well-established use Traditional use Herbal medicinal product for the treatment of Traditional herbal medicinal product used as a habitual constipation or in conditions in which demulcent preparation for the symptomatic relief easy defaecation with soft stool is desirable. of mild gastrointestinal discomfort. The product is a traditional herbal medicinal product for use in the specified indication exclusively based upon long-standing use. 1 The declaration of the active substance(s) for an individual finished product should be in accordance with relevant herbal quality guidance. 2 The material complies with the Ph. Eur. monograph (ref.: 0095). European Union herbal monograph on Linum usitatissimum L., semen EMA/HMPC/377675/2014 Page 3/8 4.2. Posology and method of administration Well-established use Traditional use Posology Posology Adolescents, adults and elderly Adolescents, adults and elderly Single dose Single dose 10 - 15 g, 5 – 10 g in 250 ml water Daily dose: 2 - 3 times daily Daily dose: up to three times during the day The use in children under 12 years of age is not The use in children under 12 years of age is not recommended (see section 4.4 ‘Special warnings recommended (see section 4.4 ‘Special warnings and precautions for use’). and precautions for use’). Duration of use Duration of use If the constipation does not resolve within 3 days, If the symptoms persist for longer than 1 week a doctor or a pharmacist should be consulted. during the use of the medicinal product, a doctor or a qualified health care practitioner should be Method of administration consulted. Oral use. Method of administration Take 10 - 15 g seeds with 150 ml water, milk, Oral use. fruit juice or similar aqueous liquid 2 - 3 times daily; then maintain adequate fluid intake. The For a mucilaginous preparation, soak 5 - 10 g product should be taken during the day at least ½ whole or broken seeds in 250 ml water for at least to 1 hour before or after intake of other <x min> and take this half an hour before eating. medicines. The effect starts 12 - 24 hours later. At the time of consumption the process of swelling has to be accomplished [length has to be specified Warning: not to be taken immediately prior to for the individual product]. The mucilaginous bedtime. preparations may be consumed with or without the seeds. 4.5. Interactions with other medicinal products and other forms of interaction Well-established use Traditional use Enteral absorption of concomitantly administered Enteral absorption of concomitantly administered medicines may be delayed by bulk forming medicines may be delayed by a demulcent laxatives such as linseed. preparation of linseed. For this reason the product should be taken at For this reason the product should not be taken ½ least ½ to 1 hour before or after intake of other to 1 hour before or after intake of other medicinal medicinal products. products. In order to decrease the risk of gastrointestinal obstruction (ileus), linseed should be used together with medicinal products known to inhibit peristaltic movement (e.g. opioids, loperamide) only under medical supervision. European Union herbal monograph on Linum usitatissimum L., semen EMA/HMPC/377675/2014 Page 5/8PDF SHA-256:
4680a197b276cea7a180c83f6bddf2797e1b0f063a5344e05c383eebe79a17c4Die Zuordnung verbindet dieses HMPC-Quellenprofil mit dem genannten Wirkstoff. Sie ist keine Aussage über jedes Präparat aus dieser Pflanzenart.
Keine oder wenige Zuordnungen bedeuten nicht, dass keine Wechselwirkungen bestehen. Nicht eindeutig zuordenbare Aussagen bleiben im Originalabschnitt nachlesbar; verneinte Befunde gelten nur für die beschriebenen Bedingungen.
Sicherheit aus der Monographie Originalabschnitte
Englische Originalabschnitte mit unveränderten Spalten für etablierte und traditionelle Anwendung. Aussagen gelten für die im Dokument genannten Zubereitungen und Anwendungsarten. Aus ihnen werden hier keine Interaktionspaare oder Schweregrade abgeleitet.
Final community herbal monograph on Linum usitatissimum L., semen ↗
PDF abgerufen: 25.10.2026 · 8 Seiten · automatisch ausgelesen
Zubereitungs- und Anwendungskontext · Originaltext
Originalkontext vor Abschnitt 4.3, einschließlich der Angaben zu Zubereitungen und Anwendung. Buchstaben und Nummern der Zubereitungen werden in den Sicherheitsabschnitten wieder aufgegriffen.
1. Name of the medicinal product
To be specified for the individual finished product.
2. Qualitative and quantitative composition 1,2
Well-established use Traditional use
With regard to the marketing authorisation With regard to the registration application of
application of Article 10(a) of Directive Article 16d(1) of Directive 2001/83/EC as
2001/83/EC as amended amended
Linum usitatissimum L., semen (linseed) Linum usitatissimum L., semen (linseed)
i) Herbal substance i) Herbal substance
As defined in the Ph. Eur. monograph As defined in the Ph. Eur. monograph
ii) Herbal preparations
ii) Herbal preparations
not applicable
not applicable
3. Pharmaceutical form
Well-established use Traditional use
Herbal substance for oral use. Herbal substance for oral use.
The pharmaceutical form should be described by The pharmaceutical form should be described by
the European Pharmacopoeia full standard term. the European Pharmacopoeia full standard term.
4. Clinical particulars
4.1. Therapeutic indications
Well-established use Traditional use
Herbal medicinal product for the treatment of Traditional herbal medicinal product used as a
habitual constipation or in conditions in which demulcent preparation for the symptomatic relief
easy defaecation with soft stool is desirable. of mild gastrointestinal discomfort.
The product is a traditional herbal medicinal
product for use in the specified indication
exclusively based upon long-standing use.
1
The declaration of the active substance(s) for an individual finished product should be in accordance with relevant herbal
quality guidance.
2
The material complies with the Ph. Eur. monograph (ref.: 0095).
European Union herbal monograph on Linum usitatissimum L., semen
EMA/HMPC/377675/2014 Page 3/8
4.2. Posology and method of administration
Well-established use Traditional use
Posology Posology
Adolescents, adults and elderly Adolescents, adults and elderly
Single dose Single dose
10 - 15 g, 5 – 10 g in 250 ml water
Daily dose: 2 - 3 times daily Daily dose: up to three times during the day
The use in children under 12 years of age is not The use in children under 12 years of age is not
recommended (see section 4.4 ‘Special warnings recommended (see section 4.4 ‘Special warnings
and precautions for use’). and precautions for use’).
Duration of use Duration of use
If the constipation does not resolve within 3 days, If the symptoms persist for longer than 1 week
a doctor or a pharmacist should be consulted. during the use of the medicinal product, a doctor
or a qualified health care practitioner should be
Method of administration
consulted.
Oral use.
Method of administration
Take 10 - 15 g seeds with 150 ml water, milk,
Oral use.
fruit juice or similar aqueous liquid 2 - 3 times
daily; then maintain adequate fluid intake. The For a mucilaginous preparation, soak 5 - 10 g
product should be taken during the day at least ½ whole or broken seeds in 250 ml water for at least
to 1 hour before or after intake of other <x min> and take this half an hour before eating.
medicines. The effect starts 12 - 24 hours later. At the time of consumption the process of swelling
has to be accomplished [length has to be specified
Warning: not to be taken immediately prior to
for the individual product]. The mucilaginous
bedtime.
preparations may be consumed with or without
the seeds.Kontext im Original-PDF öffnen ↗4.3 · Gegenanzeigen
Contraindications
4.3. Contraindications
Well-established use Traditional use
Hypersensitivity to the active substance. Hypersensitivity to the active substance.
Linseed should not be used by patients with a This product should not be taken by patients,
sudden change in bowel habit that persists for who have difficulty in swallowing or any throat
more than 2 weeks, undiagnosed rectal bleeding problems.
and failure to defaecate following the use of a
laxative.
Linseed should also not be used by patients
suffering from abnormal constrictions in the
gastro-intestinal tract, with diseases of the
oesophagus and cardia or existing intestinal
blockage (ileus), paralysis (ileus) of the intestine
or megacolon.
European Union herbal monograph on Linum usitatissimum L., semen
EMA/HMPC/377675/2014 Page 4/8
Well-established use Traditional use
This product should not be taken by patients, who
have difficulty swallowing or any throat problems.Original-PDF · Seite 4–5 ↗4.4 · Warnhinweise und Vorsichtsmaßnahmen
Special warnings and precautions for use
4.4. Special warnings and precautions for use
Well-established use Traditional use
The use is not recommended in children under 12 The use in children under 12 years of age has not
years due to insufficient data on safety and been established due to lack of adequate data.
efficacy.
The treatment of debilitated patients and elderly
If abdominal pain occurs or in cases of any should be supervised.
irregularity of frequency of faeces, the use of
Investigations in healthy women suggest that long
linseed should be discontinued and medical advice
term use of linseed may have an oestrogenic
must be sought.
effect, and its use is therefore not recommended
Taking this herbal substance without adequate in women with hormonally dependent tumours.
fluid, may cause it to swell and block the throat or
oesophagus and may cause choking. Intestinal
obstruction may occur if adequate fluid intake is
not maintained. If experiencing chest pain,
vomiting, or difficulty in swallowing or breathing
after taking this herbal substance, immediate
medical attention should be sought.
The treatment of debilitated patients and elderly
should be supervised.
Investigations in healthy women suggest that long
term use of linseed may have an oestrogenic
effect, and its use is therefore not recommended
in women with hormonally dependent tumours.Original-PDF · Seite 5 ↗4.5 · Wechselwirkungen
Interactions with other medicinal products and other forms of interaction
4.5. Interactions with other medicinal products and other forms of
interaction
Well-established use Traditional use
Enteral absorption of concomitantly administered Enteral absorption of concomitantly administered
medicines may be delayed by bulk forming medicines may be delayed by a demulcent
laxatives such as linseed. preparation of linseed.
For this reason the product should be taken at For this reason the product should not be taken ½
least ½ to 1 hour before or after intake of other to 1 hour before or after intake of other medicinal
medicinal products. products.
In order to decrease the risk of gastrointestinal
obstruction (ileus), linseed should be used
together with medicinal products known to inhibit
peristaltic movement (e.g. opioids, loperamide)
only under medical supervision.
European Union herbal monograph on Linum usitatissimum L., semen
EMA/HMPC/377675/2014 Page 5/8Original-PDF · Seite 5 ↗4.8 · Nebenwirkungen
Undesirable effects
4.8. Undesirable effects
Well-established use Traditional use
Meteorism, occurring with the use of the product, Meteorism, occurring with the use of the product,
is common. is common.
Reactions of hypersensitivity including Reactions of hypersensitivity including
anaphylaxis-like reactions may occur very rarely. anaphylaxis-like reactions may occur very rarely.
If other adverse reactions not mentioned above If other adverse reactions not mentioned above
occur, a doctor or a pharmacist should be occur, a doctor or a qualified health care
consulted. practitioner should be consulted.Original-PDF · Seite 6 ↗Dokumentfassung nachweisen
SHA-256: 4680a197b276cea7a180c83f6bddf2797e1b0f063a5344e05c383eebe79a17c4
Der Hash kennzeichnet die abgerufene Datei. Die Dokumentfassung und der Bearbeitungsstatus des Pflanzenprofils sind getrennte Angaben.
Importstand: 26.10.2026 · Aktuelles EMA-Quellenprofil ↗
Dokumente beim Herausgeber · 13
Originaltitel bleiben erhalten. Entwürfe, ältere Fassungen und ergänzende Berichte können nebeneinander vorliegen; der Profilstatus bestimmt nicht die Gültigkeit jedes Dokuments.
- Call for scientific data for the periodic review of the monograph on Lini semen
- Call for scientific data for the systematic review of the monograph on Linum usitatissimum L., semen
- Superseded overview of comments received on 'Community herbal monograph on Linum usitatissimum L., semen' EMEA/HMPC/340849/2005
- Final community herbal monograph on Linum usitatissimum L., semen
- Superseded final community herbal monograph on Linum usitatissimum L., semen
- Opinion of the Committee on Herbal Medicinal products on a community herbal monograph for Linum usitatissimum L., semen
- Superseded opinion of the Committee on Herbal Medicinal products on a community herbal monograph for Linum usitatissimum L., semen
- List of references supporting the assessment of Linum usitatissimum L., semen
- Superseded list of bibliographic references supporting the HMPC assessment report on Linum usitatissimum L. semen (EMEA/HMPC/167395/2006)
- Addendum to assessment report on Linum usitatissimum L., semen
- Assessment report on Linum usitatissimum L., semen
- Superseded assessment report on Linum usitatissimum L., semen
- Linseed - Summary for the public
Dokumentenlinks geprüft: 25.10.2026
Quellenstand & Originalangaben
- Originalstatus
- C: ongoing call for scientific data
- Zuletzt geändert laut EMA
- 12/03/2025
- Erstveröffentlichung laut EMA
- 27/01/2005
- Erfolgreicher Quellenabruf
- 26.10.2026